BELGRADE, MT, Jan. 11, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Ronald Berlin as Vice President & Chief Operations Officer, effective January 1, 2019. Mr. Berlin will report to Michael Mainelli, Xtant’s Interim Chief Executive Officer.
“Ron is an accomplished healthcare executive with significant operations and quality management expertise and we are pleased that he has joined our executive management team,” said Michael Mainelli. “In addition to the operational leadership he will provide to the organization, he is a strong strategic, cross-functional leader. His appointment continues our commitment to building a highly skilled management team.”
Ron Berlin brings over 35 years of operations experience to Xtant. Most recently, Mr. Berlin served as Vice President of Global Operations for CoorsTek Medical. Prior to that role, he held positions of Vice President, Global Strategic Sourcing and Procurement and Vice President, Operations for Integra LifeSciences. Earlier in his career, he was Vice President of Global Operations at Stryker Orthopaedics, which was at the time a division of Stryker Corporation. He is well versed in all aspects of medical device and tissue processing operations and quality assurance. He has a proven track record for improving compliance and quality, cost effectiveness, asset utilization, and continuous improvement programs based on Six Sigma, Kaizen, Lean Implementation, as well as managing the implementation of M&A programs.
“I’m particularly pleased to be joining this exceptional, newly appointed executive leadership team and look forward to helping the Company continue to transform its business and drive shareholder value”, said Ron Berlin.
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
Kathie Lenzen, Chief Financial Officer